Drug Repurposing Patent Applications October–December 2023

HAM Mucke - ASSAY and Drug Development Technologies, 2024 - liebertpub.com
Inventor: Qi X Applicant: Soochow University, Suzhou (China) Published: October 5, 2023
Mitoxantrone is an anthraquinone topoisomerase II inhibitor with a broad-spectrum …

Drug Repurposing Patent Applications October–December 2020

HAM Mucke - ASSAY and Drug Development Technologies, 2021 - liebertpub.com
Bromantane (adamantylbromphenylamine) is an anxiolytic psychostimulant developed and
used in Russia at doses of 50–100 mg for what used to be called neurasthenia. It also is a …

Drug Repurposing Patent Applications July–September 2023

HAM Mucke - ASSAY and Drug Development Technologies, 2023 - liebertpub.com
It has been found by the inventors that flunarizine, used in migraine prophylaxis, occlusive
peripheral vascular disease, and vertigo, causes mitochondria to enter the lysosomal …

Drug repurposing patent applications October–December 2016

HAM Mucke - ASSAY and Drug Development Technologies, 2017 - liebertpub.com
Desmopressin (1-desamino-8-D-arginine vasopressin; dDVAP) is a synthetic and
generically available antidiuretic peptide hormone that has been marketed for the treatment …

Drug Repurposing Patent Applications January–March 2023

HAM Mucke - ASSAY and Drug Development Technologies, 2023 - liebertpub.com
Monensin A, a lipophilic polyether antibiotic isolated from Streptomyces cinnamonensis, is
used extensively in cattle and poultry industries to prevent coccidiosis. 1 Like other …

Drug repurposing programmes get lift off

A Mullard - Nature reviews. Drug discovery, 2012 - nature.com
© 2012 Macmillan Publishers Limited. All rights reserved events” in his experience,
especially in the current era of highly optimized drug candidates. But commercial concerns …

Drug Repurposing Patent Applications April–June 2018

HAM Mucke - ASSAY and Drug Development Technologies, 2018 - liebertpub.com
Amlexanox is a tricyclic amine carboxylic acid with a complex immunomodulatory
mechanism that is not well understood. It is the agent in Aphthasol® mouthwashes and …

Drug Repurposing Patent Applications January–March 2022

HAM Mucke - ASSAY and Drug Development Technologies, 2022 - liebertpub.com
Non-nucleoside reverse transcriptase inhibitors, such as rilpivirine, which were developed to
treat HIV infection, have been found to be effective against many cancers. In some cases …

Drug Repurposing Patent Applications January–March 2019

HAM Mucke - ASSAY and Drug Development Technologies, 2019 - liebertpub.com
Autonomic dysfunction—impairment of the vegetative nervous system that unsettles the
balance between the sympathetic and parasympathetic nervous systems—is most apparent …

Not lost in translation

C Harrison - Nature Reviews Drug Discovery, 2007 - go.gale.com
Two European initiatives that aim to improve the European patent system are set to come
into force over the next few months. The first of these is the London Agreement, a treaty …